RAPT Therapeutics in San Francisco, USA, depends on INTEGRA Biosciences’ pipettes to seamlessly speed up the event of its candidate small molecule inhibitors for the therapy of inflammatory ailments and cancers. These liquid dealing with options assist the corporate’s R&D crew to effectively analyze its lead drug candidates at each stage of the method – from discovery to scientific trials – driving its modern therapies in the direction of commercialization.
RAPT Therapeutics is a scientific stage, immunology-based biopharmaceutical firm targeted on small molecule therapies for varied cancers and inflammatory ailments, and at present has 2 promising candidates in scientific trials. The corporate’s immunology laboratory makes use of INTEGRA pipettes to assist develop and carry out assays to characterize immune cell subsets after illness onset and drug administration, answering necessary questions that will come up earlier than or after scientific trials.
I work with EVOLVE guide pipettes and VIAFLO 96 digital pipettes on a day-to-day foundation, and discover their efficiency excellent. The VIAFLO 96 pipettes have been significantly helpful for enhancing our productiveness – which is important for transferring onto the following stage of a venture – as we are able to dispense complete 96 nicely plates in a single go.”
Steven Lomeli Gonzalez, Analysis Affiliate within the Immunology Division, INTEGRA Biosciences
Steven continued: “INTEGRA devices are unparalleled in relation to accuracy and precision, which has undoubtedly enhanced our immunology analysis. I’ve examined the pipettes towards totally different quantity ranges, and the pattern strains at all times look actually nice, so I’ve confidence of their pipetting accuracy. The pipettes are additionally glossy and simple to make use of, and the plunger of the EVOLVE pipettes is remarkably clean, which makes such a distinction to person consolation when pipetting manually. With our environment friendly, ergonomic and correct pipettes, we are able to proceed to progress our small molecule inhibitors by way of scientific trials to enhance most cancers and autoimmune illness therapy. That’s what is most necessary on the finish of the day; everyone knows somebody that has been impacted by these illness areas, and we hope that getting our candidates to market faster might help to enhance the prognosis for sufferers sooner or later.”
